As everyone knows, healthcare costs are genuinely sucking us dry on an individual, company and country level. Everyone is affected and biotech has the ability to make that better (or maybe worse). Come and learn from three dynamite speakers who run healthcare scenarios, figure out what costs the least and squash other healthcare problems in companies ranging from providers to large pharma companies.
Sign up immediately at https://problemsolvinginhealthcarepanel.eventbrite.com/ for “Problem Solving in Healthcare” - A panel discussion with thought leaders, Thursday, October 24 at 7 pm at the Varick Street Incubator, 137 Varick Street 2nd Floor. This is a co-sponsored event between NYC Bio and the Healthcare Professionals Network New York (HPN NY); thank HPN NY's founder Shaguna Punj.
If you are in healthcare, if you have your own business or if you simply want to meet those people who can help deal with terribly exorbitant, extraordinarily annoying costs, this event is for you.
Sam Murphy (Principal, IMS Consulting Group), Paul Mendelsohn (Chief Operating Officer, Loeb & Troper LLP) and Tom Yang (Sr. Manager, Monitor Deloitte) will present issues and their solutions in a panel format. See below. The event is totally free and a happy hour plus networking will follow as always. Again make sure to thank Shaguna when you come.
Sam Murphy, Principal at IMS Consulting Group, IMS Health has had six years of life-science strategy consulting experience with an emphasis on pricing & market access and transaction support. He has deep expertise in a wide range of therapy areas and commercialization challenges and over 10 years of drug discovery and biomedical research experience prior to consulting. He earned his PhD in Virology and BA in Biochemistry from the University of Pennsylvania.
Paul N. Mendelsohn, CPA has been the Chief Operating Officer of Loeb & Troper LLP since 2006. He has extensive experience running businesses, solving problems and advising CEOs and Managing Partners. Paul has worked in multi-state and multi-national professional services, entertainment and media companies. He started his career in a Big 4 firm and earned his Masters in Accounting from the Stern School of Business at NYU and his Bachelors in history cum laude from Princeton University. Paul invites invitations to connect on LinkedIn.
Tom Yang, Sr Manager at Monitor Deloitte, Deloitte Consulting LLP has been serving biotech and biopharmaceutical clients to drive organic growth at the intersection of their Commercial and R&D organizations for the past 8 years. Over the past several years his typical projects have focused on a wide range of topics including: corporate strategy, business development, product development, commercialization strategy, market access, and building internal client capabilities. Earlier this year, Monitor Group was acquired by Deloitte Consulting, and as a member of Deloitte, Tom is excited to bring a full suite of end-to-end offerings to his clients from strategy through to implementation. He earned his PhD in Cell and Molecular Biology from the University of Pennsylvania and a BA in Economics and Biology from Cornell University.
IMSCG has been delivering management consulting services to the biopharma industry for over 13 years. Their sole focus on life sciences, deep expertise in key commercial areas, unique access to proprietary data, and in-market presence around the world allows them to truly live up to their mission of making a positive long-term impact on healthcare. IMSCG covers a broad swath of commercial issues that face companies of all sizes and at all stages of the product lifecycle.
Loeb & Troper LLP is a consulting and CPA firm located in midtown Manhattan. Founded in 1919 the firm provides financial, planning and clinical consulting to healthcare providers, especially in the long-term care and hospital areas. Loeb & Troper is strong in consulting clients on all aspects of compliance and the emerging changes in long-term care. The audit practice serves exclusively not-for-profit clients.
Monitor Deloitte is the strategy consulting practice of Deloitte Consulting. As firms operate in this complex and rapidly-evolving environment, they need a 21st century approach to strategy that combines leading knowledge, insight, foresight, and analysis to enable confident action. Monitor Deloitte is at the forefront of this change. They work with clients to create, understand and communicate new insight and then to implement and execute strategic decisions that position them for transformative change. Their investments in innovation and research help clients build dynamic organizations to lead in an environment of constant change.